Perioperative bridging therapy for the at-risk patient on chronic anticoagulation

Disease-a-Month

Volumn 51, Issue 2-3, 2005, Pages 183-193

  Spyropoulos, Alex C ^a,b  

^a Lovelace Sandia Health Systems   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ANTICOAGULATION; CLINICAL TRIAL; COST CONTROL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; HEALTH CARE UTILIZATION; HUMAN; HYPERCOAGULABILITY; LOW DRUG DOSE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; REVIEW; THROMBOEMBOLISM;

EID: 19344372459     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2005.03.014     Document Type: Article

References (34)

1. C. Kearon, J. Hirsh Management of anticoagulation before and after elective surgery N Engl J Med 336 1997 1506 1511
2. S. Schulman, E. Svenungusen, S. Granqvist Duration of Anticoagulation Study Group Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy Am J Med 104 1998 332 338
3. J.A. Heit, D.N. Mohr, M.D. Silverstein Predictors of recurrence after deep vein thrombosis and pulmonary embolism a population-based cohort study Arch Intern Med 160 2000 761 768
4. P. Lindmarker, S. Schulman, M. Stein-Linder DURAC Trial Study Group Duration of Anticoagulation The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation Factor V gene and the G20210A allele in the prothrombin gene Thromb Haemost 81 1999 684 689
5. D.E. Singer, G.W. Albers, J.E. Dalen Antithrombotic therapy in atrial fibrillation Chest 126 2004 429S 456S
6. B.F. Gage, A.D. Waterman, W. Shannon Validation of clinical classification schemes for predicting stroke results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
7. S.C. Cannegieter, F.R. Rosendaal, A.R. Wintzen Optimal oral anticoagulant therapy in patients with mechanical heart valves N Engl J Med 333 1995 11 17
8. J. Ansell, J. Hirsh, L. Poller The pharmacology and management of vitamin K antagonists Chest 126 2004 204S 233S
9. D.J. Tiede, R.A. Nishimura, D.A. Gastineau Modern management of prosthetic valve anticoagulation Mayo Clin Proc 73 1998 665 680
10. B.J. Rowbotham, A.N. Whitaker, J. Harrison Measurement of crosslinked fibrin derivatives in patients undergoing abdominal surgery use in the diagnosis of postoperative venous thrombosis Blood Coagul Fibrinolysis 3 1992 25 31
11. F. Lindberg, D. Bergqvist, I. Rasmussen Incidence of thromboembolic complications after laparoscopic cholecystectomy review of the literature Surg Laparosc Endosc 7 1997 324 331
12. M.J. Wahl Dental surgery in anticoagulated patients Arch Intern Med 158 1998 1610 1616
13. A.S. Dunn, A.G.G. Turpie Perioperative management of patients receiving oral anticoagulants a systematic review Arch Intern Med 163 2003 901 908
14. G. Palareti, C. Legnani, G. Guazzaloca Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants--a prospective study Thromb Haemost 72 1994 222 226
15. J.D. Douketis, J.A. Johnson, A.G.G. Turpie Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin. Assessment of a standardized periprocedural anticoagulation regimen Arch Intern Med 164 2004 1319 1326
16. R.T. Weibert Oral anticoagulant therapy in patients undergoing dental surgery Clin Pharm 11 1992 857 864
17. American Society for Gastrointestinal Endoscopy Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures Gastrointest Endosc 48 1998 672 675
18. R. Collins, A. Scrimgeour, S. Yusuf Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery N Engl J Med 318 1988 1162 1173
19. J. Martinelli, A. Jimenez, G. Rabago Mechanical cardiac valve thrombosis. Is thrombectomy justified? Circulation 84 suppl 3 1991 III70 III75
20. W.T. Longstreth Jr, C. Bernick, A. Fitzpatrick Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study Neurology 56 2001 368 375
21. E. Berge, M. Abdelnoor, P.H. Nakstad Low-molecular-weight heparin versus aspirin in patients with acute ischemic stroke and atrial fibrillation: a double-blind randomized study: HAEST Study Group Lancet 355 2000 1205 1210
22. J.M. Spandorfer, S. Lynch, H.H. Weitz Use of enoxaparin for the chronically anticoagulated patient before and after procedures Am J Cardiol 84 1999 478 480
23. A.H. Tinmouth, B.H. Morrow, M.K. Cruickshank Dalteparin as periprocedure anticoagulation for patients in warfarin and at high risk of thrombosis Ann Pharmacother 35 2001 669 674
24. A.C. Spyropoulos, P. Jenkins, L. Bornikova A disease management protocol for outpatient perioperative bridge therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation Pharmacotherapy 24 2004 649 658
25. M.J. Kovacs, C. Kearon, M. Rodger Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial thromboembolism who require temporary interruption of warfarin Circulation 110 2004 1658 1663
26. A.S. Dunn, A.C. Spyropoulos, S.P. Sirko Perioperative bridging therapy with enoxaparin in patients requiring interruption of long-term oral anticoagulant therapy a multicentre cohort study Blood 104 2004 1761 1771 (abstract)
27. A.C. Spyropoulos, A.G. Turpie, A.S. Dunn Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants results from the REGIMEN registry Blood 104 2004 709 (abstract)
28. A.G. Turpie, J.D. Douketis Enoxaparin is effective and safe as bridging anticoagulation in patients with a mechanical prosthetic heart valve who require temporary interruption of warfarin because of surgery or an invasive procedure Blood 104 2004 703 (abstract)
29. R.E. Katholi, S.P. Nolan, L.B. McGuire The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study Am Heart J 96 1978 163 165
30. G. Montalescot, V. Polle, J.P. Collet Low molecular weight heparin after mechanical heart valve replacement Circulation 101 2000 1083 1086
31. I. Ferreira, L. Dos, P. Tornos Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocoumarol Heart 89 2003 527 530
32. A.C. Spyropoulos, F.J. Frost, J.S. Hurley Costs and clinical outcomes associated with low-molecular-weight-heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy Chest 125 2004 1642 1650
33. A.K. Jaffer, D.J. Brotman, N. Chukwumerije When patients on warfarin need surgery Cleve Clin J Med 70 2003 973 984
34. T.T. Horlocker, D.J. Wedel, H. Benzon Regional anesthesia in the anticoagulated patient defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation) Reg Anesth Pain Med 28 2003 172 197